ArchPoint Investors’s Abbott ABT Stock Holding History

ArchPoint Investors’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,433	Closed	-$406K	–	69
2021 Q3	$406K	Buy	+3,433	New	+$422K	0.12%	61

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

ArchPoint Investors's ABT Position: Q4 2021 in Review

ArchPoint Investors sold out of Abbott (ABT) in Q4 2021, closing a stake of 3,433 shares — an estimated $406K sold.

ArchPoint Investors first reported a position in ABT in Q3 2021 and held it in 1 quarter. The position peaked at $406K in Q3 2021. 2,813 funds tracked by Wall St. Rank hold ABT as of Q4 2021.

ArchPoint Investors reported no remaining Abbott position as of Q4 2021 after selling out during the quarter.
ArchPoint Investors sold 3,433 Abbott shares in Q4 2021, an estimated $406K.
ArchPoint Investors first reported a position in Abbott in Q3 2021 and held it in 1 quarter.
ArchPoint Investors's Abbott position peaked at $406K in Q3 2021.
2,813 funds tracked by Wall St. Rank held Abbott as of Q4 2021.

Based on ArchPoint Investors's 13F filing for Q4 2021, filed 11 Feb 2022.